CD4-话题@MedSci

#CD4#

117篇内容 | 3222人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1864234, encodeId=2d9f1864234ca, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Blood：CD44是系统性肥大细胞增多症的侵袭性受体，介导其侵袭性, objectType=article, longId=144728, objectId=744c144e286d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744c144e286d, replyNumber=0, likeNumber=83, createdTime=2018-08-13, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744c144e286d, moduleTitle=Blood：CD44是系统性肥大细胞增多症的侵袭性受体，介导其侵袭性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=744c144e286d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864237, encodeId=6814186423e56, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Asian Pac J Allergy Immunol：在中度到重度屋尘螨敏感过敏性鼻炎患者中，CD4+末端分化效应记忆T细胞减少, objectType=article, longId=145187, objectId=3c2514518ef4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c2514518ef4, replyNumber=0, likeNumber=58, createdTime=2019-01-17, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c2514518ef4, moduleTitle=Asian Pac J Allergy Immunol：在中度到重度屋尘螨敏感过敏性鼻炎患者中，CD4+末端分化效应记忆T细胞减少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c2514518ef4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864224, encodeId=da0a18642242d, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Nature：CD4/6抑制剂通过增加PD-L1表达提高免疫检查点抑制剂的治疗效果, objectType=article, longId=125917, objectId=6df412591ef3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6df412591ef3, replyNumber=0, likeNumber=59, createdTime=2018-05-06, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6df412591ef3, moduleTitle=Nature：CD4/6抑制剂通过增加PD-L1表达提高免疫检查点抑制剂的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6df412591ef3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864229, encodeId=a433186422928, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Blood：抗CD43和抗CD44抗体涂层可在液体培养基中固定小鼠/人类造血干/祖细胞, objectType=article, longId=130229, objectId=e601130229f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e601130229f7, replyNumber=0, likeNumber=77, createdTime=2019-01-12, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e601130229f7, moduleTitle=Blood：抗CD43和抗CD44抗体涂层可在液体培养基中固定小鼠/人类造血干/祖细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e601130229f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864223, encodeId=171b1864223cd, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=SCI REP：循环CD40和sCD40L水平可以预测慢性肾脏病患者的肾功能变化！, objectType=article, longId=108822, objectId=3ab710882230, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ab710882230, replyNumber=0, likeNumber=82, createdTime=2018-02-12, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ab710882230, moduleTitle=SCI REP：循环CD40和sCD40L水平可以预测慢性肾脏病患者的肾功能变化！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ab710882230)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864225, encodeId=80111864225ed, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Lancet HIV：CD4计数与HIV抗逆转录病毒药物治疗收益, objectType=article, longId=126645, objectId=4c8b12664581, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c8b12664581, replyNumber=0, likeNumber=54, createdTime=2018-10-07, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c8b12664581, moduleTitle=Lancet HIV：CD4计数与HIV抗逆转录病毒药物治疗收益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c8b12664581)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864233, encodeId=42ea1864233fc, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Sci Rep：在小鼠同种异体角膜移植中抗LAP单克隆抗体下调CD4+ LAP+ T细胞, objectType=article, longId=140770, objectId=d0c2140e700d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0c2140e700d, replyNumber=0, likeNumber=65, createdTime=2018-10-14, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0c2140e700d, moduleTitle=Sci Rep：在小鼠同种异体角膜移植中抗LAP单克隆抗体下调CD4+ LAP+ T细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0c2140e700d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864231, encodeId=8a4a1864231bd, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Clin Infect Dis：确诊HIV后高CD4也应立即开始ART？, objectType=article, longId=134099, objectId=266813409992, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=266813409992, replyNumber=0, likeNumber=43, createdTime=2018-04-24, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=266813409992, moduleTitle=Clin Infect Dis：确诊HIV后高CD4也应立即开始ART？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=266813409992)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864227, encodeId=5e89186422eac, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Liver Int：MiR-492通过CD44调节肝母细胞瘤转移特性, objectType=article, longId=127612, objectId=cffd12e61241, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cffd12e61241, replyNumber=0, likeNumber=61, createdTime=2018-08-09, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cffd12e61241, moduleTitle=Liver Int：MiR-492通过CD44调节肝母细胞瘤转移特性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cffd12e61241)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864230, encodeId=6f44186423052, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Breast cancer res：CD4阳性T细胞对早期乳腺癌患者的预测意义, objectType=article, longId=131354, objectId=9d8c131354f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d8c131354f3, replyNumber=0, likeNumber=80, createdTime=2018-11-06, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d8c131354f3, moduleTitle=Breast cancer res：CD4阳性T细胞对早期乳腺癌患者的预测意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d8c131354f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864228, encodeId=209918642286c, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Blood：BAFF和CD4+T细胞，助纣为虐，保护导致免疫性血细胞减少的长寿命的脾内浆细胞的存活, objectType=article, longId=128493, objectId=b6511284932a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6511284932a, replyNumber=0, likeNumber=82, createdTime=2018-03-09, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6511284932a, moduleTitle=Blood：BAFF和CD4+T细胞，助纣为虐，保护导致免疫性血细胞减少的长寿命的脾内浆细胞的存活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6511284932a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864222, encodeId=d4fc18642228b, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Allergy：哮喘患者血中白细胞和血清CD48水平随疾病严重程度变化！, objectType=article, longId=100120, objectId=d2c8100120af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2c8100120af, replyNumber=0, likeNumber=79, createdTime=2017-06-18, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2c8100120af, moduleTitle=Allergy：哮喘患者血中白细胞和血清CD48水平随疾病严重程度变化！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2c8100120af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864215, encodeId=79721864215a1, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Oncogene：科学家揭示CD40如何摧毁癌细胞而不让健康细胞受到伤害, objectType=article, longId=90483, objectId=d2ea9048398, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2ea9048398, replyNumber=0, likeNumber=97, createdTime=2017-12-22, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2ea9048398, moduleTitle=Oncogene：科学家揭示CD40如何摧毁癌细胞而不让健康细胞受到伤害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2ea9048398)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864218, encodeId=d830186421836, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=SCI TRANSL MED：人源化的抗CD47抗体可以有效治疗儿童恶性脑部肿瘤！, objectType=article, longId=92319, objectId=48039231991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48039231991, replyNumber=0, likeNumber=72, createdTime=2017-12-10, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48039231991, moduleTitle=SCI TRANSL MED：人源化的抗CD47抗体可以有效治疗儿童恶性脑部肿瘤！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48039231991)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864216, encodeId=ae2f18642164a, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Nat Comm: 抑制肠道中树突状细胞的CD40通路治疗肠炎, objectType=article, longId=92058, objectId=74b1920585a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74b1920585a, replyNumber=0, likeNumber=69, createdTime=2018-01-31, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74b1920585a, moduleTitle=Nat Comm: 抑制肠道中树突状细胞的CD40通路治疗肠炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74b1920585a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864217, encodeId=cb87186421e30, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Nature：重磅！发现CD4 T细胞HIV病毒库的标志物---CD32a, objectType=article, longId=92113, objectId=64c6921130d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64c6921130d, replyNumber=0, likeNumber=49, createdTime=2017-12-18, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64c6921130d, moduleTitle=Nature：重磅！发现CD4 T细胞HIV病毒库的标志物---CD32a, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64c6921130d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864220, encodeId=b5af1864220b9, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=science子刊：免疫治疗新突破！CD47抗体有望治疗5种恶性儿童脑瘤, objectType=article, longId=94621, objectId=b48494621d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b48494621d1, replyNumber=0, likeNumber=49, createdTime=2017-06-25, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b48494621d1, moduleTitle=science子刊：免疫治疗新突破！CD47抗体有望治疗5种恶性儿童脑瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b48494621d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864221, encodeId=c3191864221e4, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Nature：根据SLAMF7蛋白的表达决定是否使用anti-CD47治疗淋巴癌, objectType=article, longId=97159, objectId=b5629e159d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5629e159d2, replyNumber=0, likeNumber=66, createdTime=2017-05-17, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5629e159d2, moduleTitle=Nature：根据SLAMF7蛋白的表达决定是否使用anti-CD47治疗淋巴癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5629e159d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864219, encodeId=d8dd1864219f9, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Science：衰老造成CD4+T细胞免疫力下降和基因表达不稳定, objectType=article, longId=94162, objectId=6afd941626c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6afd941626c, replyNumber=0, likeNumber=83, createdTime=2017-08-09, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6afd941626c, moduleTitle=Science：衰老造成CD4+T细胞免疫力下降和基因表达不稳定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6afd941626c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864213, encodeId=cbba18642132d, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Nature：抗肿瘤CD47抗体有望阻止动脉粥样硬化, objectType=article, longId=73426, objectId=24bce342612, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24bce342612, replyNumber=0, likeNumber=62, createdTime=2017-06-27, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24bce342612, moduleTitle=Nature：抗肿瘤CD47抗体有望阻止动脉粥样硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24bce342612)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CD4

2020-05-29

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Blood：CD44是系统性肥大细胞增多症的侵袭性受体，介导其侵袭性

2018-08-13

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Asian Pac J Allergy Immunol：在中度到重度屋尘螨敏感过敏性鼻炎患者中，CD4+末端分化效应记忆T细胞减少

2019-01-17

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Nature：CD4/6抑制剂通过增加PD-L1表达提高免疫检查点抑制剂的治疗效果

2018-05-06

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Blood：抗CD43和抗CD44抗体涂层可在液体培养基中固定小鼠/人类造血干/祖细胞

2019-01-12

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

SCI REP：循环CD40和sCD40L水平可以预测慢性肾脏病患者的肾功能变化！

2018-02-12

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Lancet HIV：CD4计数与HIV抗逆转录病毒药物治疗收益

2018-10-07

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Sci Rep：在小鼠同种异体角膜移植中抗LAP单克隆抗体下调CD4+ LAP+ T细胞

2018-10-14

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Clin Infect Dis：确诊HIV后高CD4也应立即开始ART？

2018-04-24

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Liver Int：MiR-492通过CD44调节肝母细胞瘤转移特性

2018-08-09

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Breast cancer res：CD4阳性T细胞对早期乳腺癌患者的预测意义

2018-11-06

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Blood：BAFF和CD4+T细胞，助纣为虐，保护导致免疫性血细胞减少的长寿命的脾内浆细胞的存活

2018-03-09

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Allergy：哮喘患者血中白细胞和血清CD48水平随疾病严重程度变化！

2017-06-18

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Oncogene：科学家揭示CD40如何摧毁癌细胞而不让健康细胞受到伤害

2017-12-22

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

SCI TRANSL MED：人源化的抗CD47抗体可以有效治疗儿童恶性脑部肿瘤！

2017-12-10

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Nat Comm: 抑制肠道中树突状细胞的CD40通路治疗肠炎

2018-01-31

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Nature：重磅！发现CD4 T细胞HIV病毒库的标志物---CD32a

2017-12-18

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

science子刊：免疫治疗新突破！CD47抗体有望治疗5种恶性儿童脑瘤

2017-06-25

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Nature：根据SLAMF7蛋白的表达决定是否使用anti-CD47治疗淋巴癌

2017-05-17

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Science：衰老造成CD4+T细胞免疫力下降和基因表达不稳定

2017-08-09

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Nature：抗肿瘤CD47抗体有望阻止动脉粥样硬化

2017-06-27

科室
- - 订阅+
  - 更多科室
工具
服务